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Edited by Veli-Pekka LehtoAbstract This letter presents a novel identiﬁcation and analysis
of mobile cholesterol compounds in an experimental glioma mod-
el by 1H MRS in vivo. The cholesterol compounds turned out to
comprise as much as 17 mol% of MRS visible total lipids. The
results also imply partly associated accumulation of 1H MRS
detectable cholesterol compounds and unsaturated lipids during
gene therapy-induced apoptosis, and indicate that the contribu-
tion of cholesterol compounds cannot be bypassed in spectral
lipid analysis. The introduced 1H MRS approach facilitates a
non-invasive follow-up of mobile cholesterol compounds, paving
way for studies of tumour cholesterol metabolism in vivo.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Apoptosis leads to comprehensive changes in proton mag-
netic resonance spectroscopy (1H MRS) detectable mobile
lipids in vivo [1–3]. The intense 1H MRS lipid signals during
programmed cell death (PCD) have been assigned predomi-
nantly to mobile triglycerides within intracellular lipid droplets
[4–6] with a characteristic diameter within the micrometer
range [7]. Thus, 1H MRS allows one to study a unique tissue
compartment non-invasively in vivo [8]. 1H MRS detectable
lipids are found in experimental brain tumours, such as C6
and BT4C [9,10], and also in several human tumour types [11].
One of the key ﬁndings in 1H MRS studies of apoptosis
in vivo has been the accumulation of mono- and polyunsatu-
rated lipids during PCD [2,3]. Independent biochemical assays
have conﬁrmed these changes in unsaturated lipids, and also
indicated variations both in tissue cholesterol and cholesteryl
ester (CE) levels. Using gas–liquid chromatography, increased
content and accumulation of CEs was found in BT4C [2].
Chromatographic analyses have revealed substantially ele-*Corresponding authors.
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doi:10.1016/j.febslet.2006.07.062vated CE concentrations in human gliomas compared to nor-
mal brain tissue [12]. Also, there is some indication that tissue
CE content may increase alongside with the degree of malig-
nancy and cell proliferation [13]. However, the biological pro-
cesses leading to elevated content of CEs in gliomas and to the
variation of cholesterol compounds during PCD are still not
well understood.
Despite the unambiguous biochemical observations of CEs
in tumours, there seem to have been no studies on the potential
eﬀects of PCD on 1H MRS detectable cholesterol compounds
in vivo. Therefore, we decided to investigate whether certain
peak height anomalies in 1H MR spectra of tumours could
be explained by the presence of mobile cholesterol compounds
and their characteristic multi-component backbone resonance
beneath the fatty acid resonances. As far as we are aware, this
is the ﬁrst study to identify 1H MRS detectable mobile choles-
terol compounds during PCD in vivo. The inclusion of the
multi-component model lineshape of cholesterol backbone
into spectral analyses leads to novel biochemical information
on cholesterol compounds in vivo, and provides a more
reliable analysis of the overlapping fatty acid resonances.2. Materials and methods
2.1. Animals
Approximately 104 HSV-tk-transfected BT4C cells were inoculated
into the corpus callosum of female BDIX rats (Harlan, Netherlands,
n = 10, weighing from 220 to 280 g). To induce PCD, animals were
treated with Ganciclovir (GCV) 25 mg/kg i.p. twice daily over a period
of eight days, 3–4 weeks after inoculation (tumour diameter 3.5–5 mm)
[2]. For MR experiments, the rats were anesthetized with 1% Halo-
thane in O2/N2 (0.25/0.75) and their body temperatures were kept at
37 C using a water-heated pad. All animal experiments were carried
out according to the guidelines of The Institutional Animal Care and
Use Committee of the University of Kuopio.2.2. MRI and MRS experiments and data analyses
The MR experiments were carried out in a 4.7 T magnet (Magnex
Scientiﬁc Ltd., Abington, UK) equipped with a 170 mT/m gradient
set interfaced to a Varian UNITYINOVA console (Varian Inc., Palo
Alto, CA, USA). A half-volume surface coil (High Field Imaging,
Minneapolis, MN, USA) was used for transmission and receiving of
the MR signal.
The volume-of-interest (VOI) within tumour tissue was chosen from
coronal T2-weighted fast spin-echo MR images. The selected VOI was
shimmed using the FASTMAP method [14]. A single voxel STEAMblished by Elsevier B.V. All rights reserved.
Fig. 1. The behaviour of the averaged tumour size (n = 10) during the
8-day treatment period with apoptosis-inducing ganciclovir in HSV-
tk+ BT4C gliomas. The values are means ± S.E.M. ** (P < 0.01) and
*** (P < 0.001) stand for changes between subsequent days, using
Student’s paired t test. The inset shows a typical T2-weighted coronal
view of rat brain and tumour at the 4th treatment day and the
alignment of the 1H MRS volume-of-interest (green box).
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suppression [15] was used to obtain high quality data with a TR
(time-to-repetition) = 2.5 s, TE (time-to-echo) = 3 ms, a mixing time
of 30 ms, and 256 acquisitions. The resulting signal/noise-ratio
(SNR) for the (–CH2–)n resonance from gliomas was 61 ± 4 before
treatment. Prior to Fourier transformation, the measured free induc-
tion decays were multiplied by an exponential window function with
a line-broadening of 3 Hz. The above measurements were performed
at 0, 2, 4, 6 and 8 days from the beginning of GCV treatment.
To enable the use of a model lineshape based approach [16] in the
spectral analyses of the in vivo spectra, matching STEAMMRS exper-
iments (with 512 acquisitions) were completed for a set of in vitro
phantoms containing diﬀerent fatty acids (16:0, 18:0, 18:1, 18:2, 20:4,
and 22:6) or cholesterol in deuterated chloroform (CDCl3) at the ﬁnal
concentration of 100 mM. These data provided the experimental basis
for the mathematical construction of the model lineshapes for the fatty
acids as well as for the cholesterol backbone of mobile cholesterol com-
pounds (Cb) [17].
The fatty acid model lineshape consisted of 7 components, one for
each clearly resolvable chemical group, i.e., for the fatty acid –CH3,
(–CH2–)n, bCH2, ‚CH–CH2–CH2–, aCH2, ‚CH–CH2–CH‚ and
–CH‚CH– signals. Twenty-ﬁve individual components were needed
in the Cb model lineshape to describe the distinct cholesterol backbone
signal originating from its rather complex spin system. A model line-
shape is a molecular characteristic that can be kept ﬁxed in the analyses
of in vivo spectra [16,17]. However, some softness was accepted in the
relative ﬁxings of the half-linewidths and intensities [18] of the Cb
model lineshape to allow adjustment for potential (and unknown) bio-
physical diﬀerences between the in vitro and in vivo conditions. The
spectral range of 0.3–6.5 ppm used in the analysis contained all the res-
onances from tumour tissue. Visible resonances at around 3–4 ppm
from common brain metabolites such as creatine and phosphocreatine,
choline containing compounds, and minor resonances from inositol,
glutamine, glutamate and creatine were included into the spectral anal-
ysis as single peaks to enable a uniform analysis of the whole spectral
range. However, due to heavy signal overlap at 4.7 T, their signal areas
will not be interpreted. The tissue water peaks were analysed using the
AMARES method [19] in jMRUI software (http://www.mrui.uab.es/
mrui/). The PERCH NMR software (PERCH Solutions Ltd., Kuopio,
Finland) was used for all the lineshape ﬁtting analyses of the spectra
[20]. For all statistical analyses Student’s paired t test was used and val-
ues P < 0.05 were considered signiﬁcant. If not otherwise stated values
given are means ± S.E.M.3. Results and discussion
3.1. Detection and identiﬁcation of cholesterol compounds
Successful GCV-induced tumour eradication in the HSV-
tk+BT4C gliomas is veriﬁed in Fig. 1. The tumour size de-
creased after the 2nd day maximum value of 102 ± 10 mm3
to the size of 55 ± 4 mm3 at the end of the 8-day treatment per-
iod. A clear decrease in the tumour size was observed in all
individual animals between the 2nd day and the 8th day.
Fig. 2 shows typical in vivo 1H MRS spectra, obtained from
tumour tissue, containing clear resonances arising from the var-
ious chemical groups of lipid fatty acids [3]. However, careful
inspection of the spectra indicates that lipid fatty acid reso-
nances alone are not capable of explaining the experimental
spectra at high SNR. In vitro experiments of cholesterol, at
matching experimental conditions as used in vivo, gave the idea
that spectral features unexplainable by the lipid fatty acid reso-
nances in vivo could be due to cholesterol compounds possess-
ing a mobile cholesterol backbone. Indeed, the construction of
a cholesterol backbone model lineshape (Cb) and its use in the
spectral analyses [17] together with the lipid fatty acid reso-
nances showed a clear Cb signal, of which the characteristic res-
onance of –C(18)H3 protons at 0.6 ppm was also detectable by
eye (see Fig. 2). The data analysis thus revealed, that the Cb res-onance can cause a remarkable signal below the fatty acid reso-
nances in vivo; comprising 12.3 ± 0.8% of the total MRS visible
lipid signal in non-treated tumours. This value corresponds to
16.4 ± 1.2% cholesterol compounds in molar terms (with tri-
glycerides as the main fatty acid pool). Thus, considerable inac-
curacies are likely if, e.g., the fatty acid –CH3 resonance at
around 0.9 ppm is analysed in a standard fashion using only a
single component without taking into account the underlying
multi-component Cb signal.
Previous 1H MRS studies of BT4C rat gliomas, including
high-resolution magic angle spinning (MAS) experiments
ex vivo, have indicated that the majority of the visible reso-
nances arise from 18:1 and 18:2 unsaturated lipids [3]. How-
ever, the MAS spectra also show an observable resonance
for the cholesterol backbone –C(18)H3 group at 0.6 ppm,
though the relative contribution of cholesterol compounds ap-
pears small in comparison to the unsaturated lipid resonances
from the tumours both in vivo and ex vivo [3,21]. Nevertheless,
chromatographic analyses have indicated elevated CEs in
BT4C gliomas [2] and human tumours [12] in comparison to
normal brain tissue. There is currently compelling evidence
that the 1H MRS visible lipid resonances in tumours in vivo
originate primarily from intracellular lipid vesicles [10]. Also,
in recent MAS 1H MRS experiments with BT4C rat gliomas
ex vivo the behaviour of the polyunsaturated fatty acid
(PUFA) resonances at varied spinning rates supported the li-
pid droplet origin of these resonances [3]. A visual observation
of the clearly visible cholesterol backbone resonance –C(18)H3
at 0.6 ppm (Fig. 5 in Ref. [3]) indicates similar biophysical
behaviour as for the PUFA resonances, thereby leading to a
corresponding conclusion upon the origin in the case of choles-
terol compounds. Iorio et al. [22] have also recently showed (in
an apoptotic human lymphoblastoid cell line) that build-up of
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creased levels of both triglycerides and cholesteryl esters. The
likely molecular origin for the novel Cb resonance utilised in
our work is consequently mobile CEs within the intracellular
lipid vesicles, particularly in the case of untreated tumours.
3.2. Eﬀects of apoptosis on 1H MRS detectable lipids
The behaviour of the Cb resonance (in reference to the total
lipid signal) during treatment is illustrated for a representative
individual animal in the inset of Fig. 2. A similar increase for
the Cb resonance was observed for all the ten individual ani-
mals in the study. Fig. 3 shows the trends for all lipid signals
during the treatment period. Notably, the resonance at around
5.3 ppm, representing the unsaturated –CH‚CH– signals,
shows a continual increase during the entire treatment period.
The inset in Fig. 3 shows the behaviour of the Cb and the
unsaturated lipid resonances in reference to tissue water. Inter-
estingly, the Cb resonance shows behaviour similar to the
unsaturated lipid resonances during PCD. Hence, our resultsFig. 2. Characteristic in vivo STEAM single voxel 1H MR spectra and linesh
day 6 during ganciclovir-induced apoptosis. The lipid model signal is show
cholesterol compounds (Cb) in green, and other signals in grey. The inset
reproduce the experimental data, but the Cb signal almost exactly covers the u
for the area of the Cb signal during the treatment period. The bars are ±S.Dare in accordance with previous studies of the BT4C glioma
model and apoptosis, in which the unsaturated ‚CH–CH2–
CH‚ and –CH‚CH– resonances at around 2.8 and
5.3 ppm, respectively, were shown to increase (in reference to
tissue water) [2,3,21].
The sophisticated spectral analysis introduced here for anal-
ysing in vivo 1H MRS data from BT4C gliomas includes all of
the visible resonances, and thereby oﬀers a natural way to as-
sess the relative compositional changes in the total MRS visi-
ble lipid pool of the tumours. While the interpretation of the
metabolite changes in reference to the total lipid signal is com-
plicated by biophysical issues related to molecular structure
and interactions within the tissue, it oﬀers complementary
information on the complex processes in vivo. A particular
point of interest here is the contrasting behaviour of the unsat-
urated ‚CH–CH2–CH‚ and –CH‚CH– resonances when
referenced to the total lipid signal (Fig. 3; main) or to the tissue
water (Fig. 3; inset). The apparently diﬀerent behaviour of
these resonances suggests augmented accumulation ofape ﬁtting analysis for an individual animal at baseline (day 0) and at
n in blue, the model signal for the cholesterol backbone of mobile
at day 6 emphasises that a pure fatty acid signal only is not able to
ndetermined areas. The inset (upper left) illustrates the increasing trend
. from spectral analysis.
Fig. 3. The behaviour of all lipid resonances as observed by 1H MRS
in vivo during the 8-day ganciclovir-treatment period (per total lipid
signal; n = 10). The inset shows the behaviour of the resonances from
the mobile cholesterol compounds (Cb) and from the indicated
unsaturated lipids as referenced to tissue water (n = 5). The values
are means ± S.E.M. and given as percentage changes in relation to day
0. * (P < 0.05), ** (P < 0.01) and *** (P < 0.001) stand for changes
between the treatment day and non-treated animals (day 0), Student’s
paired t test.
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within the 1H MRS detectable mobile lipid environment dur-
ing the apoptotic processes in vivo.
It has been indicated that biophysical changes alone are not
likely to account for the observed behaviour in the 1H MRS
detectable lipids [10]. Apparent biochemical process facilitat-
ing such lipid accumulation would be enhanced uptake of ser-
um lipoproteins [12] and degradation of mitochondrial
membranes [23]. Whatever the cellular processes are that drive
the lipid accumulation and the increase in the pool of mobile
lipids, as detected by 1H MRS in vivo, it is evident from our
current ﬁndings that the contribution of mobile cholesterol
compounds cannot be overlooked.
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